[
  {
    "title": "STAT+: At drugmakers’ forum, Oz gets a friendly embrace, while Makary faces tough questions",
    "link": "https://www.statnews.com/2026/02/17/pharma-forum-highlights-industry-divide-oz-makary/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-17T23:28:45.000Z",
    "summary": "Two of health secretary Robert F. Kennedy Jr.’s top lieutenants struck decidedly different tones at a forum held Tuesday by the pharmaceutical industry group PhRMA."
  },
  {
    "title": "Bayer agrees to $7.25 billion proposed settlement over thousands of Roundup cancer lawsuits",
    "link": "https://www.statnews.com/2026/02/17/bayer-settlement-lawsuits-roundup-weedkiller-cancer/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-17T21:17:53.000Z",
    "summary": "Bayer has agreed to $7.25 billion proposed settlement over thousands of lawsuits alleging the company failed to warn people that its popular weedkiller Roundup could cause cancer."
  },
  {
    "title": "STAT+: A shakeup at HHS, a toast to bipartisanship, and a cheese poof war",
    "link": "https://www.statnews.com/2026/02/17/health-policy-news-who-is-leading-the-cdc/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-17T18:37:39.000Z",
    "summary": "You're reading the web edition of D.C. Diagnosis, STAT's guide to the ins and outs and oddities of health politics and policy"
  },
  {
    "title": "STAT+: The health care economy, and a surprising Humira chart",
    "link": "https://www.statnews.com/2026/02/17/health-care-inc-a-surprising-humira-chart-skyrizi/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-17T18:29:05.000Z",
    "summary": "This is the online version of the essential and fabulous Health Care Inc. newsletter"
  },
  {
    "title": "STAT+: Does Medicare’s ACCESS model pay enough?",
    "link": "https://www.statnews.com/2026/02/17/does-medicare-access-model-pay-enough-health-tech/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-17T15:31:50.000Z",
    "summary": "In this edition of STAT Health Tech: Payment rates for Medicare's ACCESS model, health insurers' use of AI, and more."
  },
  {
    "title": "STAT+: Psilocybin data could be good enough for approval",
    "link": "https://www.statnews.com/2026/02/17/biotech-news-compass-psilocybin-data-for-fda/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-17T14:57:05.000Z",
    "summary": "And other biotech news brought to you by The Readout newsletter"
  },
  {
    "title": "STAT+: Pharmalittle: We’re reading about China’s homegrown GLP-1 drugs, a puzzling FDA rejection, and more",
    "link": "https://www.statnews.com/pharmalot/2026/02/17/india-ireland-china-glp-lilly-novo-obesity-vaccines-peanuts-africa/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-17T14:21:26.000Z",
    "summary": "The FDA rejected a Disc Medicine therapy for a rare blood disorder, the first experimental drug to go through a new program to fast-track drug reviews"
  },
  {
    "title": "Checking in on RFK Jr.’s promises, one year later",
    "link": "https://www.statnews.com/2026/02/17/health-news-rfk-jr-promises-one-year-later/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-17T14:05:59.000Z",
    "summary": "And other health news from the Morning Rounds newsletter"
  },
  {
    "title": "STAT+: Ocular’s experimental eye drug beats low dose of Regeneron’s Eylea in late-stage trial",
    "link": "https://www.statnews.com/2026/02/17/ocular-therapeutix-axpaxli-wet-amd-treatment-compared-to-eylea-regeneron/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-17T12:00:00.000Z",
    "summary": "Ocular now plans to apply for FDA approval, but whether doctors and insurers will favor its new drug is an open question."
  },
  {
    "title": "STAT+: Compass says its psilocybin drug helped patients with severe depression in two trials",
    "link": "https://www.statnews.com/2026/02/17/compass-pathways-comp360-psilocybin-severe-depression-trial-results/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-17T11:30:00.000Z",
    "summary": "COMP360 could be the first psilocybin-based medicine to win approval."
  },
  {
    "title": "STAT+: As China’s drug industry races ahead, its GLP-1 race is accelerating too",
    "link": "https://www.statnews.com/2026/02/17/china-drug-industry-biotech-glp1/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-17T09:30:00.000Z",
    "summary": "To understand what China's fast-developing drug industry might mean for global pharmaceutical companies, look no further than the market for GLP-1 drugs."
  },
  {
    "title": "STAT+: In a financial pinch, major health insurers are turning to AI for help",
    "link": "https://www.statnews.com/2026/02/17/health-insurers-expand-ai-use-undermining-providers-trust/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-17T09:30:00.000Z",
    "summary": "Facing shrinking profits and higher costs, health insurers are accelerating adoption of AI throughout their sprawling operations."
  },
  {
    "title": "Opinion: AMA CEO: Deepfake doctors are a threat to public health",
    "link": "https://www.statnews.com/2026/02/17/deepfake-doctors-scam-ama/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-17T09:30:00.000Z",
    "summary": "Highly respected doctors on social media are endorsing questionable medical products — but they’re deepfakes, and they’re a serious problem."
  },
  {
    "title": "Opinion: When IV opioids are in short supply at the hospital, who gets pain relief?",
    "link": "https://www.statnews.com/2026/02/17/iv-opioid-shortages-ethics/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-17T09:30:00.000Z",
    "summary": "If IV opioids are in short supply, who gets pain relief — a teenager in agony with a crushed leg or an 80-year-old dying from cancer?"
  },
  {
    "title": "STAT+: Medicare Advantage growth dwindles for a second straight year",
    "link": "https://www.statnews.com/2026/02/16/medicare-advantage-membership-growth-2026-unitedhealth-humana-aetna/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-16T17:18:36.000Z",
    "summary": "Amid major changes to Medicare Advantage, some big insurers have been working to shrink their rolls."
  },
  {
    "title": "STAT+: Breakup between Brigham and Dana-Farber is getting messier fast",
    "link": "https://www.statnews.com/2026/02/16/breakup-between-brigham-and-dana-farber-is-getting-messier-fast/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-16T12:00:00.000Z",
    "summary": "What does it feel like to live in a house where your parents are getting divorced? Just ask some of the staff at Dana-Farber Cancer Institute."
  },
  {
    "title": "Opinion: How public health saved the CDC Injury Center",
    "link": "https://www.statnews.com/2026/02/16/cdc-injury-center-saved-campaign-safe-states/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-16T12:00:00.000Z",
    "summary": "In a time of uncertainty, the public health campaign to save the CDC Injury Center offers important lessons — and hope."
  },
  {
    "title": "STAT+: Kennedy says he’ll act on legal challenge to ultra-processed foods",
    "link": "https://www.statnews.com/2026/02/15/kennedy-maha-challanges-ultraprocesssed-food-not-safe-fda-gras/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-16T00:36:28.000Z",
    "summary": "Kennedy and his MAHA allies are increasingly focused on food issues as the midterms approach."
  },
  {
    "title": "Therapeutic targeting of neuroimmune mechanisms in neurodegeneration",
    "link": "https://www.nature.com/articles/s41573-025-01370-7",
    "source": "Nature Reviews Drug Discovery",
    "category": "research",
    "date": "2026-02-16T00:00:00.000Z",
    "summary": ""
  },
  {
    "title": "TIGIT’s immuno-oncology teachings",
    "link": "https://www.nature.com/articles/d41573-026-00031-7",
    "source": "Nature Reviews Drug Discovery",
    "category": "research",
    "date": "2026-02-16T00:00:00.000Z",
    "summary": ""
  },
  {
    "title": "STAT+: Exit of CDC’s acting director highlights agency’s lack of leader",
    "link": "https://www.statnews.com/2026/02/15/cdc-lacks-director-jim-oneill-susan-monarez/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-15T16:53:28.000Z",
    "summary": "The lack of a Senate-confirmed leader is deepening the turmoil at the CDC."
  },
  {
    "title": "STAT+: In court, AAP argues Kennedy’s HHS made unlawful changes to vaccine policies",
    "link": "https://www.statnews.com/2026/02/13/rfk-jr-vaccine-lawsuit-pediatricians-challenge-acip-policy-changes/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-13T22:47:48.000Z",
    "summary": "After a day of oral arguments in a packed courtroom, a Boston federal judge did not rule from the bench on a lawsuit from AAP against HHS focused on vaccines."
  },
  {
    "title": "Approvals by the China NMPA in 2025",
    "link": "https://www.nature.com/articles/d41573-026-00028-2",
    "source": "Nature Reviews Drug Discovery",
    "category": "research",
    "date": "2026-02-13T00:00:00.000Z",
    "summary": ""
  },
  {
    "title": "FDA Approves Labeling Changes to Menopausal Hormone Therapy Products",
    "link": "http://www.fda.gov/news-events/press-announcements/fda-approves-labeling-changes-menopausal-hormone-therapy-products",
    "source": "FDA Press Releases",
    "category": "regulatory",
    "date": "2026-02-12T16:17:42.000Z",
    "summary": "The U.S. Food and Drug Administration has approved drug labeling changes to six menopausal hormone therapy products, also known as hormone replacement therapy (HRT), to clarify risk considerations…"
  },
  {
    "title": "FDA Approves First-of-Its-Kind Device to Treat Pancreatic Cancer",
    "link": "http://www.fda.gov/news-events/press-announcements/fda-approves-first-its-kind-device-treat-pancreatic-cancer",
    "source": "FDA Press Releases",
    "category": "regulatory",
    "date": "2026-02-12T13:33:59.000Z",
    "summary": "The U.S. Food and Drug Administration has approved a first-of-its-kind device for the treatment of adult patients with locally advanced pancreatic cancer."
  }
]
